Decreased Brain-Derived Neurotrophic Factor in Older Adults with Bipolar Disorder

American Journal of Geriatric Psychiatry

Volumn 24, Issue 8, 2016, Pages 596-601

  Soares, Aline T ^a   Andreazza, Ana C ^b,c   Rej, Soham ^b,c   Rajji, Tarek K ^b,c   Gildengers, Ariel G ^d   Lafer, Beny ^a   Young, L Trevor ^b,c   Mulsant, Benoit H ^b,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF TORONTO   (Canada)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

aging; bipolar disorder; brain derived neurotrophic factor; elderly

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; LITHIUM;

ADULT; AGING; ARTICLE; BIPOLAR DISORDER; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HAMILTON DEPRESSION RATING SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROTEIN BLOOD LEVEL; PSYCHOPHARMACOTHERAPY; YOUNG MANIA RATING SCALE; AGED; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; MULTICENTER STUDY; ONTARIO; PENNSYLVANIA; PSYCHOLOGICAL RATING SCALE;

AGED; AGING; BIPOLAR DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LITHIUM; MALE; MIDDLE AGED; ONTARIO; PENNSYLVANIA; PSYCHIATRIC STATUS RATING SCALES;

EID: 84990847745     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1016/j.jagp.2016.02.052     Document Type: Article

References (34)

1. 1 Goldstein, B.I., Young, L.T., Toward clinically applicable biomarkers in bipolar disorder: focus on BDNF, inflammatory markers, and endothelial function. Curr Psychiatry Rep, 15, 2013, 425.
2. 2 Andreazza, A.C., Young, L.T., The neurobiology of bipolar disorder: identifying targets for specific agents and synergies for combination treatment. Int J Neuropsychopharmacol 17 (2014), 1039–1052.
3. 3 Phillips, H.S., Hains, J.M., Laramee, G.R., et al. Widespread expression of BDNF but not NT3 by target areas of basal forebrain cholinergic neurons. Science 250 (1990), 290–294.
4. 4 Gray, J.D., Milner, T.A., McEwen, B.S., Dynamic plasticity: the role of glucocorticoids, brain-derived neurotrophic factor and other trophic factors. Neuroscience 239 (2013), 214–227.
5. 5 Weinstein, G., Beiser, A.S., Choi, S.H., et al. Serum brain-derived neurotrophic factor and the risk for dementia: the Framingham Heart Study. JAMA Neurol 71 (2014), 55–61.
6. 6 Erickson, K.I., Prakash, R.S., Voss, M.W., et al. Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume. J Neurosci 30 (2010), 5368–5375.
7. 7 Karege, F., Schwald, M., Cisse, M., Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett 328 (2002), 261–264.
8. 8 Klein, A.B., Williamson, R., Santini, M.A., et al. Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int J Neuropsychopharmacol 14 (2011), 347–353.
9. 9 Fernandes, B.S., Gama, C.S., Cereser, K.M., et al. Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis. J Psychiatr Res 45 (2011), 995–1004.
10. 10 Machado-Vieira, R., Andreazza, A.C., Viale, C.I., et al. Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neurosci Lett 421 (2007), 33–36.
11. 11 de Oliveira, G.S., Cereser, K.M., Fernandes, B.S., et al. Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients. J Psychiatr Res 43 (2009), 1171–1174.
12. 12 Malhi, G.S., Tanious, M., Das, P., et al. Potential mechanisms of action of lithium in bipolar disorder. Current understanding. CNS Drugs 27 (2013), 135–153.
13. 13 Goldstein, B.I., Collinger, K.A., Lotrich, F., et al. Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders. J Child Adolesc Psychopharmacol 21 (2011), 479–484.
14. 14 Yatham, L.N., Kapczinski, F., Andreazza, A.C., et al. Accelerated age-related decrease in brain-derived neurotrophic factor levels in bipolar disorder. Int J Neuropsychopharmacol 12 (2009), 137–139.
15. 15 Kauer-Sant'Anna, M., Kapczinski, F., Andreazza, A.C., et al. Brain-derived neurotrophic factor and inflammatory markers in patients with early- versus late-stage bipolar disorder. Int J Neuropsychopharmacol 12 (2009), 447–458.
16. 16 Lotrich, F.E., Butters, M.A., Aizenstein, H., et al. The relationship between interleukin-1 receptor antagonist and cognitive function in older adults with bipolar disorder. Int J Geriatr Psychiatry 29 (2014), 635–644.
17. 17 Bega, S., Schaffer, A., Goldstein, B., et al. Differentiating between bipolar disorder types I and II: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J Affect Disord 138 (2012), 46–53.
18. 18 Harkavy-Friedman, J.M., Keilp, J.G., Grunebaum, M.F., et al. Are BPI and BPII suicide attempters distinct neuropsychologically?. J Affect Disord 94 (2006), 255–259.
19. 19 Bas, T.O., Poyraz, C.A., Bas, A., et al. The impact of cognitive impairment, neurological soft signs and subdepressive symptoms on functional outcome in bipolar disorder. J Affect Disord 174 (2015), 336–341.
20. 20 Gildengers, A.G., Butters, M.A., Chisholm, D., et al. Cognition in older adults with bipolar disorder versus major depressive disorder. Bipolar Disord 14 (2012), 198–205.
21. 21 Rajji, T.K., Voineskos, A.N., Butters, M.A., et al. Cognitive performance of individuals with schizophrenia across seven decades: a study using the MATRICS consensus cognitive battery. Am J Geriatr Psychiatry 21 (2013), 108–118.
22. 22 Andreazza, A.C., Gildengers, A., Rajji, T.K., et al. Oxidative stress in older patients with bipolar disorder. Am J Geriatr Psychiatry 23 (2015), 314–319.
23. 23 Young, R.C., Biggs, J.T., Ziegler, V.E., et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133 (1978), 429–435.
24. 24 Hamilton, M., A rating scale for depression. J Neurol Neurosurg Psychiatry 23 (1960), 56–62.
25. 25 Cunha, A.B., Frey, B.N., Andreazza, A.C., et al. Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci Lett 398 (2006), 215–219.
26. 26 Berk, M., Kapczinski, F., Andreazza, A.C., et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 35 (2011), 804–817.
27. 27 Tsai, S.Y., Kuo, C.J., Chung, K.H., et al. Cognitive dysfunction and medical morbidity in elderly outpatients with bipolar disorder. Am J Geriatr Psychiatry 17 (2009), 1004–1011.
28. 28 Rej, S., Yu, C., Shulman, K., et al. Medical comorbidity, acute medical care use in late-life bipolar disorder: a comparison of lithium, valproate, and other pharmacotherapies. Gen Hosp Psychiatry 37 (2015), 528–532.
29. 29 Kessing, L.V., Vradi, E., Andersen, P.K., Life expectancy in bipolar disorder. Bipolar Disord 17 (2015), 543–548.
30. 30 Forty, L., Ulanova, A., Jones, L., et al. Comorbid medical illness in bipolar disorder. Br J Psychiatry 205 (2014), 465–472.
31. 31 Baldessarini, R.J., Leahy, L., Arcona, S., et al. Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders. Psychiatr Serv 58 (2007), 85–91.
32. 32 Lee, J., Seroogy, K.B., Mattson, M.P., Dietary restriction enhances neurotrophin expression and neurogenesis in the hippocampus of adult mice. J Neurochem 80 (2002), 539–547.
33. 33 Dwivedi, Y., Involvement of brain-derived neurotrophic factor in late-life depression. Am J Geriatr Psychiatry 21 (2013), 433–449.
34. 34 Polyakova, M., Stuke, K., Schuemberg, K., et al. BDNF as a biomarker for successful treatment of mood disorders: a systematic and quantitative meta–analysis. J Affect Disord 174 (2015), 432–440.